Cellenion
Private Company
Total funding raised: $18.2M
Overview
Cellenion is a specialized provider of high-precision instrumentation for single-cell isolation and 3D cellular model handling, addressing critical needs in advanced life science research and drug discovery. Its core technology, the cellenONE® platform, enables gentle, image-based dispensing of individual cells and is complemented by the upcoming spheroONE® system for organoids and spheroids. The company operates on a product and consumables business model, supported by contract services, and is positioned at the intersection of the rapidly growing single-cell analysis and complex 3D model markets. Backed by the manufacturing and innovation heritage of its parent company SCIENION, Cellenion is established as a trusted tool provider for leading research institutions.
Technology Platform
Precision microdispensing platform combining high-resolution imaging with non-contact picolitre dispensing for gentle isolation of single cells and 3D cellular models (spheroids, organoids). Core technology includes the cellenONE® and upcoming spheroONE® instruments, and the proteoCHIP® consumable line for single-cell proteomics.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Cellenion competes in the single-cell isolation and dispensing segment against companies like Berkeley Lights (now part of Bruker), Cytena (part of BICO), and On-chip Biotechnologies, as well as flow cytometry-based sorters. In the 3D model handling space, it faces emerging competition from specialized automation companies. Its differentiation lies in its open-platform flexibility, gentle piezo-dispensing technology, and integrated imaging for precise selection.